Form 4: Astrana Health COO/CFO Adjusts Holdings

Chandan Basho, COO and CFO of Astrana Health, Inc., reported a transaction involving the surrender of shares to cover tax withholding obligations upon the vesting of restricted stock.

Summary

• Chandan Basho, COO and CFO of Astrana Health, Inc. (ASTH), filed a Form 4 reporting a transaction on May 16, 2026.
• The transaction involved the surrender of 8,155 shares of common stock to offset tax withholding obligations related to the vesting of restricted stock on the same date.
• Following this transaction, Basho beneficially owns 159,610 shares of common stock.
• This ownership includes 15,202 unvested restricted shares scheduled to vest on May 16, 2027.
• Additionally, Basho holds restricted stock units (RSUs) totaling 15,604, vesting in semi-annual installments starting October 2, 2026, and 20,027 RSUs vesting in semi-annual installments starting September 5, 2026, all contingent on continued employment.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard administrative transaction for tax purposes related to executive compensation rather than a strategic financial move.

Positives

• The COO and CFO continues to hold a significant number of shares (159,610) in Astrana Health, indicating ongoing commitment.
• Vesting of restricted stock and RSUs demonstrates continued employee incentive and retention programs.

Negatives

• The surrender of shares to cover tax withholding obligations represents a reduction in the number of shares directly held by the executive, although it is a standard practice for tax management.

Risks

• The vesting of restricted stock and RSUs is subject to continuous employment, implying a risk of forfeiture if employment is terminated before vesting dates.
• Future vesting schedules for RSUs indicate potential for further share disposals to cover tax liabilities as these units vest.

Future Outlook

The filing details future vesting schedules for restricted stock units, indicating potential future transactions related to tax obligations as these units vest in installments starting in September and October 2026, and May 2027.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions, common across the healthcare and technology sectors. The specific details of stock vesting and tax withholding are standard compensation practices.

Stakeholder Impact

• Shareholders: The transaction itself does not directly impact the company's outstanding shares but reflects executive compensation practices. Continued insider ownership is generally viewed positively.
• Employees: The vesting of RSUs and restricted stock reinforces the company's incentive programs for key personnel.
• Management: The transaction is a standard part of executive compensation and tax management for Chandan Basho.

Next Steps

• Monitoring of future vesting dates for restricted stock and RSUs.
• Observation of any further transactions by Chandan Basho as RSUs vest.

Key Dates

Keywords

Form 4, Chandan Basho, Astrana Health, ASTH, Insider Transaction, Stock Vesting, Tax Withholding, Restricted Stock, RSU, Beneficial Ownership